New malaria therapy for children gets first approval
A new combination drug therapy against a type of malaria in kids aged 2 to 16 has received the first approval from Australian regulators. The single-dose tafenoquine (Kozenis), administered together with the standard chloroquine therapy, was developed by UK drug major GlaxoSmithKline (GSK) in partnership… Read More »New malaria therapy for children gets first approval